Document is current

Any future updates will be listed below

Effect of prophylactic or pre-emptive use of tyrosine kinase inhibitors post-Allo SCT in bcr-abl positive acute lymphoblastic leukemia: a subanalysis of GITMO ph-positive ALL study

Crossref DOI link: https://doi.org/10.1038/s41409-022-01618-5

Published Online: 2022-02-24

Published Print: 2022-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark